Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (Company abbreviation: Shenqi Pharmaceutical) is a pharmaceutical manufacturing holding investment company specializing in the research and development and production of anti-tumor, cardiovascular and cerebrovascular, cold and cough relieving, children's medicines and antifungal drugs. and sales companies. The company is a listed company of A and B shares on the Shanghai Stock Exchange (stock code: A shares: 600613; B shares: 900904).

The company's "magic" brand has a business history of more than 30 years. The company has formed a brand culture, brand awareness, reputation and influence of "magic national medicine, the most important thing in efficacy" across the country. Shenqi Pharmaceutical currently has 11 production bases in Guiyang, Longli, Duyun, and Luodian, covering a total area of ​​about 1,000 mu. It has more than 10 dosage forms and 37 production lines, all of which have passed the national compliance inspection. Shenqi Pharmaceutical is investing in the construction of a new factory area in Guiyang High-tech Development Zone, covering an area of ​​300 acres. Shenqi Pharmaceutical will strive to build the new factory into a modern pharmaceutical technology industrial park that is efficient, economical, green and environmentally friendly, human-oriented, and sustainable.

Shenqi Pharmaceutical adheres to the mission of "through continuous innovation, committed to providing high-quality products and services for people's health", and always adheres to the company's production quality policy of "quality is the magic, and efficacy is amazing". At the same time, the company also has famous domestic and foreign drugs. The research institution has established a long-term cooperative relationship and has developed 14 national medicines with independent intellectual property rights and more than 80 national invention patents. The company's R&D and technological innovation capabilities have been recognized by the society.

The company's products include both prescription drugs and OTC varieties, mainly in eight major fields such as anti-tumor series, cardiovascular and cerebrovascular series, cough and cold series, magic doll children series, anti-fungal series, and nourishing products. 141 national drug-accurate font products , sold in more than 100 cities at or above the prefecture level in 31 provinces (cities, autonomous regions) across the country.

While growing and growing, Fanqi Pharmaceutical has always maintained a strong sense of social responsibility and never forgets to repay the society. It has donated more than 200 million yuan to pave roads and bridges in Guizhou, targeted assistance to farmers in poor areas, and built primary and secondary schools. It has also invested in establishing "Poor Student Scholarships" at Beijing University of Traditional Chinese Medicine, Shenyang Pharmaceutical University and Guizhou University of Nationalities to help poor students complete Study. In March 2002, the "Guangcai Rehabilitation Project" was implemented, and 120 million yuan of anti-tuberculosis drug pasoniazid tablets (formerly tuberculosis Kangxin tablets) were provided free of charge to 12 poor counties in Africa and the west through the Ministry of Health.